...
首页> 外文期刊>Open Forum Infectious Diseases >The Control of Methicillin-Resistant Staphylococcus aureus Blood Stream Infections in England
【24h】

The Control of Methicillin-Resistant Staphylococcus aureus Blood Stream Infections in England

机译:耐甲氧西林金黄色葡萄球菌血流感染的控制

获取原文
           

摘要

Methicillin-resistant Staphylococcus aureus (MRSA) blood stream infection (BSI) is a major healthcare burden in some but not all healthcare settings, and it is associated with 10%–20% mortality. The introduction of mandatory reporting in England of MRSA BSI in 2001 was followed in 2004 by the setting of target reductions for all National Health Service hospitals. The original national target of a 50% reduction in MRSA BSI was considered by many experts to be unattainable, and yet this goal has been far exceeded (~80% reduction with rates still declining). The transformation from endemic to sporadic MRSA BSI involved the implementation of serial national infection prevention directives, and the deployment of expert improvement teams in organizations failed to meet their improvement trajectory targets. We describe and appraise the components of the major public health infection prevention campaign that yielded major reductions in MRSA infection. There are important lessons and opportunities for other healthcare systems where MRSA infection remains endemic.
机译:耐甲氧西林金黄色葡萄球菌(MRSA)血流感染(BSI)在某些(但不是全部)医疗机构中是主要的医疗负担,并且与10%–20%的死亡率有关。英格兰于2001年开始强制性报告MRSA BSI,随后在2004年为所有国家卫生服务医院设定了降低目标。许多专家认为,将MRSA BSI降低50%的最初国家目标是无法实现的,但这一目标已大大超出了目标(降低率约80%)。从地方性MRSA BSI到零星的MRSA BSI的转变涉及到实施一系列国家预防感染指令,并且组织中的专家改进团队的部署未能达到其改进目标。我们描述并评估了主要公共卫生感染预防运动的组成部分,这些运动导致了MRSA感染的大量减少。对于MRSA感染仍很普遍的其他医疗系统,有重要的教训和机会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号